Which nerves and vessels must be avoided, and what technique ensures a safe intramuscular injection in the deltoid and gluteal muscles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safe Intramuscular Injection Technique in Deltoid and Gluteal Regions

Critical Neurovascular Structures at Risk

For deltoid injections, the axillary nerve and posterior circumflex humeral artery are the primary structures at risk, located approximately 8-9 cm below the acromion, while for gluteal injections, the superior gluteal nerve and artery, along with the sciatic nerve, pose the greatest danger. 1, 2

Deltoid Region Anatomy

The axillary nerve and its accompanying posterior circumflex humeral artery traverse the deltoid region at a mean distance of 8.19 cm and 8.66 cm respectively from the mid-acromial point 1. Recent ultrasound studies confirm the axillary nerve is typically located 1.8 cm below the axillary horizontal line at a depth of 2.6 cm 3. The radial nerve runs more inferiorly, approximately 9.4 cm caudally from standard landmarks 3.

The subdeltoid bursa represents another critical structure—its inferior margin sits at approximately 2.5 cm depth, and penetration can cause shoulder injury related to vaccine administration (SIRVA) including bursitis 3.

Gluteal Region Anatomy

In the dorsogluteal region, the superior gluteal artery lies only 6.83 mm from the injection site, and the superior gluteal nerve is 5.67 mm away 2. The sciatic nerve courses through the gluteal region and is vulnerable to injury, particularly with improper technique 4.

The ventrogluteal site offers superior safety margins: the superior gluteal artery is 13.87 mm away and the nerve is 11.82 mm distant—approximately twice the distance compared to dorsogluteal injections 2.

Evidence-Based Safe Injection Technique

Deltoid Injections

The safest deltoid injection site is 4 cm (approximately 2 fingerbreadths) distal to the posterolateral corner of the acromion, using arm adduction position 5, 6.

Needle selection by body weight:

  • <60 kg: Use 0.625-inch (16 mm) needle 6
  • 60-70 kg: Use 1-inch (25 mm) needle 7, 6
  • 70-118 kg (males) or 70-90 kg (females): Use 1-inch needle in posterolateral trajectory 6
  • >118 kg (males) or >90 kg (females): Use 1.5-inch needle 6

Step-by-step technique:

  1. Position the patient with arm in adduction (relaxed at side), not with hand on hip—this position maintains optimal distance from neurovascular structures 5, 8

  2. Locate the injection site: Identify the posterolateral corner of the acromion, then measure 4 cm (2 fingerbreadths) distally along a line parallel to the humerus 5, 6. This site is more posterior and inferior than traditional teaching.

  3. Avoid the upper deltoid: Never inject in the upper half of the deltoid muscle—the axillary nerve risk is unacceptably high 1

  4. Insert at 90-degree angle perpendicular to skin surface 7

  5. Depth control: For injection sites 3-3.5 cm below the axillary horizontal line, limit needle depth to <1.7 cm to avoid subdeltoid bursa penetration 3

Gluteal Injections

The ventrogluteal site is the first-choice gluteal injection site due to superior safety margins from neurovascular structures 2.

Ventrogluteal technique (strongly preferred):

  1. Patient positioning: Lateral or supine position

  2. Landmark identification:

    • Place palm of opposite hand on greater trochanter
    • Point index finger toward anterior superior iliac spine
    • Spread middle finger posteriorly along iliac crest
    • Injection site is in the V formed between index and middle fingers
  3. Needle selection: Use 1.5-inch needle for adequate muscle penetration (mean muscle thickness 22.22 mm) 2

  4. Insert perpendicular to skin surface

Dorsogluteal technique (use only if ventrogluteal not feasible):

This site has significantly higher risk of neurovascular injury and should be avoided when possible 2, 4. If absolutely necessary:

  1. Divide buttock into quadrants
  2. Inject only in upper outer quadrant
  3. Use 1.5-inch needle (mean muscle thickness 28.35 mm) 2
  4. Recognize this provides only half the safety margin of ventrogluteal site 2

Universal Safety Measures

For all intramuscular injections:

  • Cleanse skin with alcohol swab 9, 10

  • Use 26-27 gauge needle with 0.5-1.5 inch length depending on site and patient size 9, 10

  • Pinch and lift skin away from muscle to ensure subcutaneous tissue clearance and avoid inadvertent intravenous injection 9

  • Aspiration debate: While CDC guidelines state aspiration is unnecessary at recommended sites 9, the potential benefit of detecting blood return outweighs minimal inconvenience—aspirate before injecting 9, 10

  • If blood appears: Discard syringe, draw fresh dose, select different site 10

  • Inject slowly to avoid wheal formation and excessive pain 10

  • Apply mild pressure for 1 minute post-injection to prevent leakage 10

Common Pitfalls to Avoid

Critical errors that increase injury risk:

  1. Injecting too high in deltoid—the most common error leading to axillary nerve injury and SIRVA 1, 3

  2. Using hand-on-hip position for deltoid injections—this moves the injection site closer to the acromion and may alter neurovascular anatomy 8

  3. Choosing dorsogluteal over ventrogluteal site—doubles the risk of neurovascular injury 2

  4. Using needles that are too short—fails to reach muscle, particularly in patients with higher BMI 6

  5. Using 1.5-inch needles in patients <118 kg—creates high risk of overpenetration into deeper structures 6

  6. Injecting anterior or superior to recommended landmarks—significantly increases overpenetration risk 6

Special Populations

Lean patients (BMI <19 kg/m²): Higher risk of unintentional deep penetration; use shorter needles and consider skin lift technique 11

Pregnant women: Standard sites acceptable; use lateral abdominal areas in 2nd-3rd trimester or implement skin lift 11

Children: Use 4 mm needles with skin lift technique; avoid syringe needles in children <6 years 11

Southeast Asian adults: Use individualized 2-fingerbreadth landmark with 0.5-inch needle for reliable intramuscular delivery while avoiding smaller frame complications 5

References

Research

Sciatic nerve injury following intramuscular injection: a case report and review of the literature.

The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2006

Guideline

allergen immunotherapy: a practice parameter third update.

Journal of Allergy and Clinical Immunology, 2011

Guideline

allergen immunotherapy: a practice parameter second update.

Journal of Allergy and Clinical Immunology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.